Nivolumab vs Valproic Acid

## Nivolumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Valproic Acid**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Valproic Acid**: Enhances GABA transmission and blocks sodium/calcium channels.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Valproic Acid — 9-16 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Valproic Acid — C8H16O2.

**Molecular Weight**: Nivolumab — N/A; Valproic Acid — 144.2110 g/mol.

**Type**: Nivolumab — Antibody; Valproic Acid — Small molecule.